Arcutis Canada, Inc., a commercial-stage company focused on delivering meaningful innovations in immuno-dermatology, is pleased to announce that Health Canada has approved PrZORYVE® (roflumilast foam ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback